{
    "medicine_id": "6c24df0542019b9949e20bb1042a42f4f74d8e34",
    "platform_id": "DB08893",
    "metadata": {
        "name": "Betmiga 25 mg Tablet extended release",
        "composition": "25 mg Mirabegron",
        "clinical_particulars": {
            "therapeutic_indications": "Mirabegron is a beta 3 adrenergic agonist indicated for the treatment of overactive bladder OAB with symptoms of urge urinary incontinence urgency and urinary frequency",
            "contraindications": {
                "disease": "Most commonly reported adverse reactions 2 and placebo were hypertension nasopharyngitis urinary tract infection and headache",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mirabegron has little effect on the mean maximum flow rate or mean detrusor pressure at maximum flow rate in patients with lower urinary tract symptoms and bladder outlet obstruction Furthermore mirabegron increases blood pressure in a dose dependent manner However this effect is reversible when mirabegron is discontinued Mirabegron also increases heart rate in a dose dependent manner The dose in which half maximal efficacy is demonstrated is 25 mg Comparatively the dose in which maximal efficacy is demonstrated is 100 mg",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Afatinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Colchicine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Ledipasvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The serum concentration of Naloxegol can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Pazopanib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The serum concentration of Prucalopride can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Mirabegron may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Mirabegron may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Mirabegron may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Mirabegron may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Mirabegron may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Mirabegron may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Mirabegron may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Mirabegron may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Mirabegron may decrease the antihypertensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Mirabegron may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Mirabegron may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Mirabegron may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Mirabegron may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Mirabegron may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Mirabegron may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Mirabegron may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Mirabegron may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Mirabegron may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Mirabegron may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Mirabegron may decrease the antihypertensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Mirabegron may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Mirabegron may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Mirabegron may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Mirabegron may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Mirabegron may decrease the antihypertensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Mirabegron may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Mirabegron may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Mirabegron may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Mirabegron may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Mirabegron may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Mirabegron may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Mirabegron may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Mirabegron may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Mirabegron may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Mirabegron may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Mirabegron may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Mirabegron may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Mirabegron may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Mirabegron may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Mirabegron may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Mirabegron may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Mirabegron may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Mirabegron may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Mirabegron may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Mirabegron may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Mirabegron may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Mirabegron may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Mirabegron may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Mirabegron may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Mirabegron may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Mirabegron may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Mirabegron may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Mirabegron may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Mirabegron may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Mirabegron may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Mirabegron may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Mirabegron may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Mirabegron may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Mirabegron may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Mirabegron may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Mirabegron may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Mirabegron may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Everolimus can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Rifaximin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of urinary retention can be increased when Tramadol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of urinary retention can be increased when Trospium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of urinary retention can be increased when Oxyphenonium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of urinary retention can be increased when Benzatropine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of urinary retention can be increased when Disopyramide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of urinary retention can be increased when Amitriptyline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of urinary retention can be increased when Ipratropium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of urinary retention can be increased when Olanzapine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of urinary retention can be increased when Metixene is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of urinary retention can be increased when Terfenadine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of urinary retention can be increased when Buclizine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of urinary retention can be increased when Clozapine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of urinary retention can be increased when Doxylamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of urinary retention can be increased when Trihexyphenidyl is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of urinary retention can be increased when Oxyphencyclimine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of urinary retention can be increased when Procyclidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of urinary retention can be increased when Profenamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of urinary retention can be increased when Promazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of urinary retention can be increased when Hyoscyamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of urinary retention can be increased when Cyproheptadine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of urinary retention can be increased when Imipramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of urinary retention can be increased when Methscopolamine bromide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of urinary retention can be increased when Chlorpromazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of urinary retention can be increased when Gallamine triethiodide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of urinary retention can be increased when Darifenacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of urinary retention can be increased when Tridihexethyl is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of urinary retention can be increased when Triflupromazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of urinary retention can be increased when Anisotropine methylbromide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of urinary retention can be increased when Nortriptyline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of urinary retention can be increased when Amoxapine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of urinary retention can be increased when Lamotrigine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of urinary retention can be increased when Atropine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of urinary retention can be increased when Nicardipine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of urinary retention can be increased when Pirenzepine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of urinary retention can be increased when Paroxetine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of urinary retention can be increased when Homatropine methylbromide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of urinary retention can be increased when Rocuronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of urinary retention can be increased when Scopolamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of urinary retention can be increased when Benzquinamide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of urinary retention can be increased when Clidinium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of urinary retention can be increased when Propiomazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of urinary retention can be increased when Propantheline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of urinary retention can be increased when Dicyclomine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of urinary retention can be increased when Biperiden is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of urinary retention can be increased when Brompheniramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of urinary retention can be increased when Flupentixol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of urinary retention can be increased when Cocaine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of urinary retention can be increased when Quinidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of urinary retention can be increased when Maprotiline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of urinary retention can be increased when Methantheline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of urinary retention can be increased when Cycrimine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of urinary retention can be increased when Glycopyrronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of urinary retention can be increased when Tolterodine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of urinary retention can be increased when Oxybutynin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of urinary retention can be increased when Promethazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of urinary retention can be increased when Diphenhydramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of urinary retention can be increased when Doxacurium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of urinary retention can be increased when Doxepin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of urinary retention can be increased when Flavoxate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of urinary retention can be increased when Orphenadrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of urinary retention can be increased when Escitalopram is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of urinary retention can be increased when Quetiapine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of urinary retention can be increased when Mivacurium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of urinary retention can be increased when Diphenidol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of urinary retention can be increased when Aripiprazole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of urinary retention can be increased when Chlorprothixene is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of urinary retention can be increased when Metocurine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of urinary retention can be increased when Pancuronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of urinary retention can be increased when Pipecuronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of urinary retention can be increased when Methotrimeprazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of urinary retention can be increased when Tiotropium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of urinary retention can be increased when Isopropamide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of urinary retention can be increased when Rapacuronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of urinary retention can be increased when Mepenzolate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of urinary retention can be increased when Pizotifen is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of urinary retention can be increased when Fesoterodine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of urinary retention can be increased when Hexocyclium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of urinary retention can be increased when Dimetindene is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of urinary retention can be increased when Aclidinium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of urinary retention can be increased when Dexetimide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of urinary retention can be increased when Benactyzine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of urinary retention can be increased when Umeclidinium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of urinary retention can be increased when Trimebutine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of urinary retention can be increased when Dosulepin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of urinary retention can be increased when Imidafenacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of urinary retention can be increased when Butylscopolamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of urinary retention can be increased when Thonzylamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of urinary retention can be increased when Methscopolamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The risk or severity of urinary retention can be increased when Revefenacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of urinary retention can be increased when Oxitropium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of urinary retention can be increased when Propiverine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of urinary retention can be increased when Batefenterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of urinary retention can be increased when Mebeverine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of urinary retention can be increased when Tropatepine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of urinary retention can be increased when Prifinium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of urinary retention can be increased when Piperidolate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of urinary retention can be increased when Benzilone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of urinary retention can be increased when Difemerine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of urinary retention can be increased when Phenglutarimide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of urinary retention can be increased when Mazaticol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of urinary retention can be increased when Etybenzatropine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of urinary retention can be increased when Otilonium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of urinary retention can be increased when Emepronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of urinary retention can be increased when Poldine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of urinary retention can be increased when Bevonium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of urinary retention can be increased when Rociverine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of urinary retention can be increased when Bornaprine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of urinary retention can be increased when Etanautine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of urinary retention can be increased when Tiemonium iodide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of urinary retention can be increased when Dihexyverine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of urinary retention can be increased when Penthienate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of urinary retention can be increased when Diphemanil is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of urinary retention can be increased when Camylofin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of urinary retention can be increased when Fenpiverinium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of urinary retention can be increased when Emetonium iodide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of urinary retention can be increased when Pipenzolate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of urinary retention can be increased when Timepidium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of urinary retention can be increased when Mirabegron is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of urinary retention can be increased when Chlorphenoxamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of hypertension can be increased when Bethanidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of hypertension can be increased when Isoetharine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of hypertension can be increased when Zolmitriptan is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of hypertension can be increased when Norepinephrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Phenylephrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of hypertension can be increased when Linezolid is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypertension can be increased when Metaraminol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of hypertension can be increased when Furazolidone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of hypertension can be increased when Guanabenz is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypertension can be increased when Methoxamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of hypertension can be increased when Orciprenaline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of hypertension can be increased when Ritodrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypertension can be increased when Remifentanil is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of hypertension can be increased when Bitolterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Oxymetazoline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of hypertension can be increased when Diethylpropion is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of hypertension can be increased when Naratriptan is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of hypertension can be increased when Frovatriptan is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of hypertension can be increased when Isoprenaline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of hypertension can be increased when Arbutamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of hypertension can be increased when Isocarboxazid is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of hypertension can be increased when Fenoterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of hypertension can be increased when Pirbuterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypertension can be increased when Ephedrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypertension can be increased when Mephentermine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of hypertension can be increased when Procaterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of hypertension can be increased when Clenbuterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of hypertension can be increased when MMDA is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of hypertension can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of hypertension can be increased when Tenamfetamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of hypertension can be increased when Chlorphentermine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of hypertension can be increased when Pargyline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of hypertension can be increased when Clorgiline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of hypertension can be increased when Nialamide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Amibegron is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of hypertension can be increased when Naluzotan is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Solabegron is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of hypertension can be increased when Nitrous oxide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Xylometazoline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Isometheptene is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Levonordefrin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Naphazoline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypertension can be increased when Tetryzoline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of hypertension can be increased when Cinitapride is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Tyramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Doxofylline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypertension can be increased when Midodrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of hypertension can be increased when Phentermine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of hypertension can be increased when Epinephrine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypertension can be increased when Sufentanil is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of hypertension can be increased when Benzphetamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of hypertension can be increased when Halothane is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypertension can be increased when Nylidrin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypertension can be increased when Alfentanil is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypertension can be increased when Fentanyl is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Mirabegron may decrease the antihypertensive activities of Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Mirabegron may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Atomoxetine"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "Cinchocaine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "Isoflurophate may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "Diethylcarbamazine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "Mechlorethamine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "Demecarium may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "Physostigmine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "Rivastigmine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "Ambenonium may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Bambuterol may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "1 10 Phenanthroline may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "Thiotepa may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "Huperzine A may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "Phenserine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "Regramostim may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "Aprotinin may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "Glycine betaine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "Coumaphos may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "Dichlorvos may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "Fenthion may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "Metrifonate may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "Acotiamide may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "Methanesulfonyl Fluoride may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "Paraoxon may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "Tyrothricin may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "Ipidacrine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "Distigmine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "Tretamine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "Posiphen may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "Pyridostigmine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "Methylphosphinic Acid may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "Pegvisomant may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "Capsaicin may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "Tacrine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "Neostigmine may increase the neuromuscular blocking activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Propafenone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The serum concentration of Erlotinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The serum concentration of Theophylline can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The serum concentration of Astemizole can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The serum concentration of Pimozide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The serum concentration of Sotalol can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The serum concentration of Procainamide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The serum concentration of Flecainide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Ponatinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The serum concentration of Clonidine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of adverse effects can be increased when Mirabegron is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The excretion of Vincristine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The serum concentration of Doxorubicin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Mirabegron may increase the hypertensive and vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Mirabegron may increase the hypertensive and vasoconstricting activities of Ergotamine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Mirabegron may increase the hypertensive and vasoconstricting activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may increase the tachycardic activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may increase the tachycardic activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may increase the tachycardic activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Mirabegron can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Alfuzosin"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Indoramin"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Trimazosin"
                    },
                    {
                        "drugbank-id": "DB12230",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bunazosin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Urapidil"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The therapeutic efficacy of Prazosin can be decreased when used in combination with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The therapeutic efficacy of Terazosin can be decreased when used in combination with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of hypertension can be increased when Amineptine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of hypertension can be increased when Oxaprotiline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of hypertension can be increased when Dibenzepin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of hypertension can be increased when Quinupramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of hypertension can be increased when Melitracen is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of hypertension can be increased when Lofepramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of hypertension can be increased when Iprindole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of hypertension can be increased when Imipramine oxide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Artemether is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The metabolism of Dexchlorpheniramine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The metabolism of Citalopram can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Imatinib can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The metabolism of Domperidone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The metabolism of Bepridil can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The metabolism of Paliperidone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Zuclopenthixol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The metabolism of Tetrabenazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The metabolism of Deutetrabenazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Rucaparib can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Cinnarizine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The metabolism of Dolasetron can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The metabolism of Chlorpheniramine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Azelastine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The metabolism of Eletriptan can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The metabolism of Risperidone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The metabolism of Donepezil can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The metabolism of Metoclopramide can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The metabolism of Celiprolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The metabolism of Talinolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Palonosetron"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lisuride"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Galantamine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Phenacetin"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Alogliptin"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The metabolism of Opium can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The metabolism of Rupatadine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Esmolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nicergoline"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Meclizine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Encainide"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Practolol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Aprindine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The metabolism of Mirabegron can be decreased when combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bicifadine"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Repinotan"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tafenoquine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Enclomiphene"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bopindolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The metabolism of Anisodamine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The metabolism of 5 methoxy N N dimethyltryptamine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Phenytoin can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The metabolism of Opipramol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Cisapride can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Mirabegron can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Mirabegron may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Mirabegron can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Palbociclib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Velpatasvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Valspodar can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pibrentasvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Glecaprevir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Ivosidenib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Fedratinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Idelalisib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Rifamycin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Ripretinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Prednisolone phosphate can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Mirabegron may decrease the excretion rate of Loxoprofen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Tositumomab may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Carmustine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Fluocinolone acetonide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Dacarbazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Azathioprine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Mycophenolic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Probenecid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Flucytosine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Capecitabine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Ifosfamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Gemfibrozil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Hydralazine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Amrinone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Pentaerythritol tetranitrate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Droxidopa may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Saxagliptin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Pralatrexate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Mirabegron may decrease the excretion rate of Peginesatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Mirabegron may decrease the excretion rate of Teduglutide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Mirabegron may decrease the excretion rate of Formestane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Mirabegron may decrease the excretion rate of Trametinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Mirabegron may decrease the excretion rate of Macitentan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Mirabegron may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Mirabegron may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Mirabegron may decrease the excretion rate of Tasimelteon which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Mirabegron may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Mirabegron may decrease the excretion rate of Tixocortol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Mirabegron may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Mirabegron may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Mirabegron may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Mirabegron may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Mirabegron may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Mirabegron may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Mirabegron may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Mirabegron may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Mirabegron may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Mirabegron may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Mirabegron may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Mirabegron may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Mirabegron may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Mirabegron may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Mirabegron may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Mirabegron may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Mirabegron may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Mirabegron may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Mirabegron may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Mirabegron may decrease the excretion rate of Viloxazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Mirabegron may decrease the excretion rate of Etoperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Mirabegron may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Mirabegron may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Mirabegron may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Mirabegron may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Mirabegron may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Mirabegron may decrease the excretion rate of Blonanserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Mirabegron may decrease the excretion rate of Pirlindole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Mirabegron may decrease the excretion rate of Toloxatone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Mirabegron may decrease the excretion rate of Dextran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Mirabegron may decrease the excretion rate of Tegafur which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Mirabegron may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Mirabegron may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Mirabegron may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Mirabegron may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Mirabegron may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Mirabegron may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Mirabegron may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Mirabegron may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Mirabegron may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Mirabegron may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Mirabegron may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Mirabegron may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Mirabegron may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Mirabegron may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Mirabegron may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Mirabegron may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Mirabegron may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Mirabegron may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Mirabegron may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Mirabegron may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Mirabegron may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Mirabegron may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Mirabegron may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Mirabegron may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Mirabegron may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Mirabegron may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Mirabegron may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Mirabegron may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Mirabegron may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Mirabegron may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Mirabegron may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Mirabegron may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Mirabegron may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Mirabegron may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Mirabegron may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Mirabegron may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Mirabegron may decrease the excretion rate of Pyrantel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Mirabegron may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Mirabegron may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Mirabegron may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Mirabegron may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Mirabegron may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Mirabegron may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Mirabegron may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Mirabegron may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Mirabegron may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Mirabegron may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Mirabegron may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Mirabegron may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Mirabegron may decrease the excretion rate of Tropisetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Mirabegron may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Mirabegron may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Mirabegron may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Mirabegron may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Mirabegron may decrease the excretion rate of Tiapride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Mirabegron may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Mirabegron may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Mirabegron may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Mirabegron may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Mirabegron may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Mirabegron may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Mirabegron may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Mirabegron may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Mirabegron may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Mirabegron may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Mirabegron may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Mirabegron may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Mirabegron may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Mirabegron may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Mirabegron may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Mirabegron may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Mirabegron may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Mirabegron may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Mirabegron may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Mirabegron may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Mirabegron may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Mirabegron may decrease the excretion rate of Tadalafil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Mirabegron may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Mirabegron may decrease the excretion rate of Nisoldipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Prednisone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Budesonide may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Mirabegron may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Mirabegron may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Mirabegron may decrease the excretion rate of Estradiol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Mirabegron may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Mirabegron may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Mirabegron may decrease the excretion rate of Estradiol valerate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Mirabegron may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Mirabegron may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Mirabegron may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Mirabegron may decrease the excretion rate of Difluocortolone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Mirabegron may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Mirabegron may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Mirabegron may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Mirabegron may decrease the excretion rate of Cisplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Mirabegron may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Mirabegron may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Mirabegron may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Warfarin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Carbamazepine may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Mirabegron may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Mirabegron may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Mirabegron may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Mirabegron may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Ceritinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Romidepsin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Regorafenib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Dabrafenib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Venetoclax can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The serum concentration of Dasatinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Mirabegron can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Levosalbutamol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Rilpivirine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Mirabegron can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of Mirabegron can be decreased when combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Mirabegron can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Certolizumab pegol can be increased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Mirabegron can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Mirabegron can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Mirabegron can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Mirabegron can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Mirabegron can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Mirabegron can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Mirabegron can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Mirabegron can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Mirabegron can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Mirabegron can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Mirabegron can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Mirabegron can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Mirabegron can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Guanadrel"
                    },
                    {
                        "drugbank-id": "DB12057",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with ORM 12741"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of Tachycardia can be increased when Nabilone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Protokylol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia can be increased when Rimonabant is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of Tachycardia can be increased when Mirabegron is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of Tachycardia can be increased when Dronabinol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Succinylcholine"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Chloroprocaine"
                    },
                    {
                        "drugbank-id": "DB05875",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB04250",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Butyrylthiocholine"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00892",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Oxybuprocaine"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The serum concentration of Baricitinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Ertugliflozin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Methylene blue can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Saquinavir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Mirabegron may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Mirabegron may decrease the excretion rate of Metildigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Mirabegron may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Mirabegron may increase the QTc prolonging activities of Lefamulin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Mirabegron can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Formoterol may increase the sympathomimetic activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Mirabegron may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The serum concentration of Oliceridine can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Mirabegron can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Pralsetinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB14895",
                        "description": "Mirabegron may increase the smooth muscle relaxing activities of Vibegron"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}